Sectors

PMVP
PMV Pharmaceuticals, Inc.
1.30
20 x 1.18
5 x 1.30
bid
ask
+
0.07
5.69%
1 @ 04:00 PM
1.30 +0.00 (0.00%)
Ytd4.00%
1y-7.14%
1.22
day range
1.32
1.02
52 week range
1.88
Open1.22Prev Close1.23Low1.22High1.32Mkt Cap69.33M
Vol314.86KAvg Vol358.82KEPS-1.49P/E-0.87Forward P/E-0.96
Beta1.48Short Ratio5.17Inst. Own83.89%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1350-d Avg1.20200-d Avg1.281yr Est5.80

PMVP News

PMV Pharmaceuticals (PMVP) Upgraded to Buy: Here's Why
zacks.com
PMV Pharmaceuticals (PMVP) Upgraded to Buy: Here's Why

PMV Pharmaceuticals (PMVP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism a

PMV Pharmaceuticals (PMVP) Loses 26% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
zacks.com
PMV Pharmaceuticals (PMVP) Loses 26% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corne

PMV Pharmaceuticals (PMVP) is technically in oversold territory now, so the heavy selling pressure m

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

PMV Pharmaceuticals Announces Board Chair Transition
globenewswire.com
PMV Pharmaceuticals Announces Board Chair Transition

Rich Heyman to retire from PMV Pharma Board of Directors; Laurie Stelzer, Director since 2020, appoi

PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights
globenewswire.com
PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights

PRINCETON, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “

PMV Pharmaceuticals (NASDAQ:PMVP) versus Aurinia Pharmaceuticals (NASDAQ:AUPH) Financial Comparison
defenseworld.net
PMV Pharmaceuticals (NASDAQ:PMVP) versus Aurinia Pharmaceuticals (NASDAQ:AUPH) Financial Comparison

Aurinia Pharmaceuticals (NASDAQ: AUPH - Get Free Report) and PMV Pharmaceuticals (NASDAQ: PMVP - Get

PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation
globenewswire.com
PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phas

PRINCETON, N.J., Oct. 24, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “C

Small-Cap PMV Pharmaceuticals Cancer Drug Shows Confirmed Responses In 8 Tumor Types
benzinga.com
Small-Cap PMV Pharmaceuticals Cancer Drug Shows Confirmed Responses In 8 Tumor Types

PMV Pharmaceuticals, Inc. PMVP on Wednesday released interim data from the Phase 2 pivotal portion o

benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

PMV Pharmaceuticals Announces Promising Rezatapopt Monotherapy Interim Data From PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation
globenewswire.com
PMV Pharmaceuticals Announces Promising Rezatapopt Monotherapy Interim Data From PYNNACLE Phase 2 Tr

PRINCETON, N.J., Sept. 10, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “

PMV Pharmaceuticals (PMVP) Q2 Loss Jumps
fool.com
PMV Pharmaceuticals (PMVP) Q2 Loss Jumps

PMV Pharmaceuticals (PMVP) Q2 Loss Jumps

PMV Pharmaceuticals Reports Second Quarter 2025 Financial Results and Corporate Highlights
globenewswire.com
PMV Pharmaceuticals Reports Second Quarter 2025 Financial Results and Corporate Highlights

PRINCETON, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “C

PMV Pharmaceuticals to Participate at Upcoming Investor Conferences
globenewswire.com
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences

PRINCETON, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma”; Nasdaq: P

Here's Why PMV Pharmaceuticals (PMVP) Looks Ripe for Bottom Fishing
zacks.com
Here's Why PMV Pharmaceuticals (PMVP) Looks Ripe for Bottom Fishing

PMV Pharmaceuticals (PMVP) witnesses a hammer chart pattern, indicating support found by the stock a

PMV Pharmaceuticals Reports Full Year 2024 Financial Results and Corporate Highlights
globenewswire.com
PMV Pharmaceuticals Reports Full Year 2024 Financial Results and Corporate Highlights

Enrollment on track in Phase 2 pivotal portion of PYNNACLE clinical trial evaluating rezatapopt as m

PMV Pharmaceuticals to Participate at Upcoming Investor Conferences
globenewswire.com
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences

PRINCETON, N.J., Feb. 11, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a preci

Here's Why PMV Pharmaceuticals (PMVP) Could be Great Choice for a Bottom Fisher
zacks.com
Here's Why PMV Pharmaceuticals (PMVP) Could be Great Choice for a Bottom Fisher

PMV Pharmaceuticals (PMVP) appears to have found support after losing some value lately, as indicate

Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator
businesswire.com
Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezata

BOSTON & PRINCETON, N.J.--(BUSINESS WIRE)--Foundation Medicine and PMV Pharma partner to develop Fou

Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator
globenewswire.com
Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezata

BOSTON and PRINCETON, N.J., May 29, 2024 (GLOBE NEWSWIRE) -- Foundation Medicine, Inc. and PMV Pharm

PMV Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Highlights
globenewswire.com
PMV Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Highlights

PRINCETON, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precis

PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors
globenewswire.com
PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial fo

PRINCETON, N.J., March 27, 2024 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a prec

PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women's Cancer
globenewswire.com
PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-

PRINCETON, N.J., March 18, 2024 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a prec

benzinga.com
Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Ses

Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enh

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  Monday's session saw 114 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 497 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 135 companies reached new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  Monday saw 196 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 951 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  During Monday's trading, 1214 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 422 stocks made new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  During the Thursday's session, 100 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  During Thursday, 849 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

    On Friday, 209 companies set new 52-week lows.

benzinga.com
58 Biggest Movers From Yesterday

Gainers Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs after the comp

benzinga.com
64 Biggest Movers From Yesterday

Gainers HighPoint Resources Corporation (NYSE: HPR) shares jumped 118.8% to close at $10.83 on We

benzinga.com
Stocks That Hit 52-Week Highs On Monday

  During Monday's morning session, 286 stocks hit new 52-week highs.

benzinga.com
Stocks That Hit 52-Week Highs On Wednesday

  Wednesday morning saw 335 companies set new 52-week highs.